Dr Simon Fifer, CaPPRe (Community and Patient Preference Research, NSW)
Important decisions regarding treatment must be made by men with prostate cancer. A treatment decision is usually made by these men and their physicians. Partners and families will often make valuable contributions to this process. Men must choose between management strategies that carry different risks of side-effects and different chances of benefit. The choice of best management for prostate cancer is viewed as a trade-off between the risk of disease progression and the risk of side effects. Other factors, such as cost and effect on quality of life, are also important. This shared decision-making process will have the best outcomes if the treatment goals are aligned with the patient’s own values. Patient preference research seeks to understand what is important to individual patients, in order to guide this decision-making process.
The aim of this study was to understand the preferences of Australian men with metastatic prostate cancer.
This study involved a one hour interview by phone or in person. The interview was designed to ask what is important to men with metastatic prostate cancer, when making decisions about their treatment.
Ethics approval has been granted through the Human Research Ethics Advisory at Bellberry Limited.
This study is no longer recruiting participants